Drug Discovery News: Breaking Drug Discovery News, Comments and Articles. - Page: 4

23:39 EST 22nd November 2014 | BioPortfolio

Drug Discovery News - Page: 4Twitter RSS

Read the latest Drug Discovery News from around the world, updated every five minutes. Breaking stories from leading news and press agencies, bloggers and experts on Drug Discovery.

Search or Follow Our Drug Discovery - Page: 4 News…

If you are looking for more stories, you may wish to search our extensive news archives for relevant stories: Search for More Drug Discovery - Page: 4 News.
You can also follow our Drug Discovery - Page: 4 news stories on Twitter: @DiscoveryDrug

Showing "drug drug discovery discovery" News Articles 76 to 100 of 27,000+

Friday 21st November 2014

What Does It Cost to Develop a Drug? Latest Study Says $2.6 Billion

How much does it cost to develop a drug and win FDA marketing approval? A new study from a nonprofit think tank says nearly $2.6 billion is needed to get a new drug from the lab to the launchpad.

Big Bud Farms to be Featured in Upcoming Episode of Innovations with Ed Begley Jr.

DMG Productions explores the latest breakthroughs in medical marijuana. Orange County, CA (PRWEB) November 21, 2014 Big Bud Farms announced today that they will be featured in an upcoming episode of Innovations with Ed Begley Jr., airing via Discovery Channel 2nd QTR 2015. Dates and show times TBA. Big Bud Farms, growers of legal medical marijuana, provide the public with information for growing,...

Adverse Effects of Testosterone Replacement Therapy

What does research say about safety of testosterone therapy in men? Therapeutic Advances in Drug Safety


Opioid overdose reversals double since emergency order signed by Governor Patrick BOSTON – Friday, November 21, 2014 – The Department of Public Health (DPH) today announced grant awards to 23 communities across Massachusetts to help first responders save lives by providing funding for opioid overdose response training and naloxone units that can be used to reverse overdoses. Police and fire de...

Basilea reports that U.S. FDA sets date of Advisory Committee meeting on isavuconazole NDA for the treatment of invasive aspergillosis and mucormycosis

Basilea Pharmaceutica AG / Basilea reports that U.S. FDA sets date of Advisory Committee meeting on isavuconazole NDA for the treatment of invasive aspergillosis and mucormycosis . Processed and transmitted by NASDAQ OMX Corporate Solutions. The issuer is solely responsible for the content of this announcement. Basel, Switzerland, November 21, 2014 - Basilea Pharmaceutica Ltd. (SIX: BSLN) report...

UK aims to shave years off drug development

The UK government has announced an 'end to end' review of how drugs are developed, approved and accessed by patients in a bid to make the country a leader in biomedical innovation.The new Innovative Medicines and MedTech Review has been announced by ...

TNF Inhibitors Not Tied to Higher Melanoma Risk in RA

(MedPage Today) -- Findings from analysis of 11 European biologic drug registries.

Oncology specialists say UK's capacity crisis is impacting patient care

A survey carried out by Swiss drug major Roche has shown that frontline staff believe patient care is suffering as a result of cancer capacity challenges in the NHS.

Proteo, Inc. / Proteo Biotech AG: Final Analysis of the Phase II Clinical Study on Elafin in Coronary Artery Bypass Surgery Completed

Proteo, Inc. (OTCQB: PTEO) and its wholly-owned subsidiary Proteo Biotech AG today announced that the NHS Lothian’s Edinburgh Heart Centre has completed final analysis of data from the investigator initiated Phase II clinical trial (EMPIRE study) with Proteo’s drug candidate Elafin for prevention of myocardial injury after coronary artery bypass surger...

Particle Sciences' Clinical Trial Supplies Group Manufactures Innovative Vaginal Ring

BETHLEHEM, Pa., Nov. 21, 2014 /PRNewswire/ -- Particle Sciences, Inc (PSI), the leading CDMO for drug eluting devices, has developed and manufactured a new innovative vaginal ring for Ladee Pharma Research Institute (LPRI), the Research and Development arm of Exeltis Pharmaceuticals.  According to Bruce Frank, Vice President of Project Management at Particle Sciences, "This vaginal ring ...

Personalized cancer drugmaker Blueprint Medicines rakes in $50M Series C

Blueprint Medicines recently announced a $50 million Series C round, meant to advance its two lead candidates through clinical trials in 2015 and fund the company’s proprietary kinase discovery platform...

Celgene Receives Positive CHMP Opinion for OTEZLA® (apremilast), the First Oral PDE4 Inhibitor for the Treatment of Patients with Psoriasis and Psoriatic Arthritis

Celgene International Sàrl (NASDAQ: CELG), a wholly-owned subsidiary of Celgene Corporation, today announced that the European Medicines Agency’s (EMA) Committee for Medicinal Products for Human Use (CHMP) has adopted a positive opinion for OTEZLA® (apremilast), the Company’s oral selective inhibitor of phosphodiesterase 4 (PDE4), in two therapeutic ...

National Rise In Patients Seeking Headache Relief

TruDenta, the creator of a diagnostic and treatment system for chronic headaches and other jaw-related symptoms, has reported a nationwide rise in the number of patients seeking relief from chronic head pain, neck pain, TMJ (temporomandibular joint) disorder, jaw pain, tinnitus, and vertigo. Ft. Lauderdale, Florida (PRWEB) November 21, 2014 TruDenta, the creator of a diagnostic and treatment syst...

Generic Drug Price Sticker Shock Prompts Probe by Congress

The prices of some common generic drugs have skyrocketed in recent years, but the reasons remain murky, lawmakers said.The hearing of the Senate subcommittee on primary health and aging on Thursday was called after Vermont Sen. Bernie Sanders and Mar...

Valeant trims stake in Allergan to 0.1% from 9.7%, launches $2 bln stock buyback plan

Valeant Pharmaceuticals International (TSE:VRX), Canada’s largest drug-maker, said it cut its stake in Allergan (NYSE:AGN) to 0.1 percent from 9.7 percent, three days after Actavis Plc (NYSE:ACT) trumped its offer for the Botox maker. Pershing ...

M3 Global Research Announces Leadership Team Promotions in US and EU

Key leadership changes announced for M3 Global Research, part of M3 Group, that digitally reaches over 2.5 million physicians worldwide. Washington, DC; London, UK (PRWEB) November 21, 2014 M3 Global Research, a market leader with the world’s only ISO verified healthcare professional panel, today announced two important leadership changes to help accelerate the company’s global growth: the a...

AARP Reports Find Brand Name Rx Prices Soar as Older New Yorkers Struggle to Pay for the Basics

NEW YORK, Nov. 20, 2014 /PRNewswire-USNewswire/ -- Just being able to afford their housing costs has more than half of older New Yorkers worried, but today a new AARP report delivered more bad news: their prescription drug prices are soaring at an alarming rate. According to an AARP Public Policy Institute (PPI) report, retail prices for brand name prescription drugs widely used by older New ...

Chinese guidelines for biosimilars

Last update:  21 November 2014Since 2003, the China Food and Drug Administration (CFDA) (simplified Chinese: 国家食品药品监督管理局) is the Chinese authority that oversees all drug manufacturing, trade, and registration.

Future bleak for Novartis' myeloma drug

Novartis suffered a major disappointment with the negative FDA panel vote for multiple myeloma candidate Farydak earlier this month, but further testing could resurrect the drug, says an analyst. The FDA's Oncologic Drugs Advisory Committee (ODAC) voted 5-2 against approval of Farydak (panobinostat) - a pan-deacetylase (pan-DAC) inhibitor - as a combination therapy with Takeda's Velcade (bortezomi...

Discovery could lead to new drugs to stop many solid-tumor cancers

In a step forward in the battle against cancer, researchers have identified promising compounds to inhibit a key driver of many forms of the disease, including lung, prostate, colon, bladder and pancreatic cancer.

Research team treats brain injuries in mice using bone marrow stem cells and antioxidants

Researchers of CEU Cardenal Herrera University (CEU-UCH) for the first time transplanted bone marrow stem cells into damaged brain tissue while applying lipoic acid (a potent antioxidant), with the aim of improving neuroregeneration in the tissue. Th...

AZE Technology announces FDA approval of Phoenix

AZE Technology announced the US Food and Drug Administration (FDA) approval of Phoenix (Volume Registration Viewer), a viewer developed with a completely new concept for efficient and accurate image interpretation.

FDA awards breakthrough status to Sanofi-Regeneron's dermatitis drug

Sanofi and Regeneron Pharmaceuticals' experimental drug dupilumab has received breakthrough-therapy status from the FDA for u -More- 

Janssen submits 3-month schizophrenia drug formulation for FDA review

Janssen Research & Development, a Johnson & Johnson unit, has filed an application with the FDA for approval to market a thre -More- 

BerGenBio's leukemia drug receives orphan designation

BerGenBio's investigational acute myeloid leukemia drug BGB324 has received orphan drug status from the FDA.  -More- 

Search BioPortfolio:

News Quicklinks